Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
Share this Article:
Tweet
|
Company
I-MED Pharma
Headquarters
Quebec, Canada
Management
Daniel Hofmann, President and CEO
Description
I-MED Pharma is a Canadian medical device company specializing in dry eye diagnosis and management. I-MED Pharma creates and distributes the most effective and advanced solutions to eye disorders like cataracts, corneal degeneration, dry eye and meibomian gland dysfunction (MGD). The firm’s latest product, I-DROP® MGD, is a premium, preservative-free artificial tear that will help relieve symptoms associated with evaporative dry eye. It contains a lipid layer enhancer and osmoprotectant that offers much-needed relief to patients. Currently, I-MED Pharma’s ocular surface disease product range includes diagnostic tools, ocular hygiene cleansers, nutritional supplements, dry eye drops, and therapeutic accessories. Over the last 30 years, the firm has brought over 40 different products from concept to market
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info